首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1547681

全球肠外营养市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Parenteral Nutrition Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球肠外营养市场需求预计将从 2023 年的 76.1 亿美元达到 2032 年近 134.1 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 6.49%。

当患者的消化系统无法从食物中吸收营养时，肠外营养将必需的营养直接输送到血液中。这些营养液透过静脉注射，含有均衡的碳水化合物、蛋白质、脂肪、维生素和矿物质，以满足患者的营养需求。这种特殊形式的营养支持通常用于重症监护环境中，治疗严重营养不良、胃肠道疾病或接受重大手术的患者。

市场动态

推动肠外营养市场的因素包括慢性病发病率的上升、刺激了多种外科手术以及全球老年人口的不断扩大。肠外营养对于控制重症患者的营养不良、支持手术復原和维持健康至关重要。此外，医疗技术和配方的进步促进了专门解决方案的创建，旨在满足特定患者群体的营养需求，例如早产儿、癌症患者和胃肠道疾病患者。此外，这种营养品在家庭医疗保健环境和门诊护理中的广泛应用进一步推动了市场成长。此外，医院和医疗机构越来越多地采用全肠外营养（TPN）和周边肠外营养（PPN）以及医疗保健支出和报销政策的增加有助于市场的扩张。然而，监管限制和有限的报销选择可能会阻碍未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球肠外营养市场的每个细分市场进行了包容性评估。肠外营养产业的成长和趋势为本研究提供了整体方法。

市场区隔

肠外营养市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依营养素

碳水化合物
肠外脂质乳剂
单剂量氨基酸溶液
微量元素
维生素和矿物质

按阶段

成人
儿科

按指示

阿兹海默症
营养缺乏
癌症护理
糖尿病
慢性肾臟病
孤儿病
吞嚥困难
疼痛管理
吸收不良/胃肠道疾病/腹泻
其他的

按销售管道

网上销售
零售销售
机构销售

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲肠外营养市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。肠外营养市场的主要参与者包括百特、Grifols、SA、艾尔建、大冢製药厂有限公司、阿特维斯公司、B. Braun Melsungen AG、Fresenius Kabi AG、Vifor Pharma、四川科伦製药有限公司、辉瑞公司（霍升瑞公司）。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 依营养成分进行市场吸引力分析
- 分阶段市场吸引力分析
- 按指标进行的市场吸引力分析
- 按销售管道分類的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球肠外营养市场分析：依营养素分类

按营养素概述
历史和预测数据
按营养素分析
碳水化合物
肠外脂质乳剂
单剂量氨基酸溶液
微量元素
维生素和矿物质

第 6 章：全球肠外营养市场分析：依阶段

按阶段概述
历史和预测数据
阶段分析
成人
儿科

第 7 章：全球肠外营养市场分析：按迹象分类

按指示概述
历史和预测数据
按指标分析
阿兹海默症
营养缺乏
癌症护理
糖尿病
慢性肾臟病
孤儿病
吞嚥困难
疼痛管理
吸收不良/胃肠道疾病/腹泻
其他的

第 8 章：全球肠外营养市场分析：依销售管道

销售通路概览
历史和预测数据
按销售管道分析
网上销售
零售销售
机构销售

第 9 章：全球肠外营养市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：肠外营养公司的竞争格局

肠外营养市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
Baxter

公司概况
公司收入
产品
最新动态

Grifols

公司概况
公司收入
产品
最新动态

公司概况
公司收入
产品
最新动态

Allergan

公司概况
公司收入
产品
最新动态

Otsuka Pharmaceutical Factory Inc.

公司概况
公司收入
产品
最新动态

Actavis Inc.

公司概况
公司收入
产品
最新动态

B. Braun Melsungen AG

公司概况
公司收入
产品
最新动态

Fresenius Kabi AG

公司概况
公司收入
产品
最新动态

Vifor Pharma

公司概况
公司收入
产品
最新动态

Sichuan Kelun Pharmaceutical Co. Ltd.

公司概况
公司收入
产品
最新动态

Pfizer Inc. (Hospira Inc.)

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11213929

The global demand for Parenteral Nutrition Market is presumed to reach the market size of nearly USD 13.41 Billion by 2032 from USD 7.61 Billion in 2023 with a CAGR of 6.49% under the study period 2024-2032.

Parenteral nutrition delivers essential nutrients directly into the bloodstream when a patient's digestive system cannot absorb nutrients from food. Administered intravenously, these nutrition solutions contain a balanced mix of carbohydrates, proteins, fats, vitamins, and minerals tailored to meet the patient's nutritional needs. This specialized form of nutrition support is commonly utilized in critical care settings for patients experiencing severe malnutrition, gastrointestinal disorders, or those undergoing major surgeries.

MARKET DYNAMICS

The factors driving the parenteral nutrition market include the growing incidence of chronic diseases, spurring several surgical procedures, and the expanding geriatric population worldwide. Parenteral nutrition is crucial in managing malnutrition, supporting recovery from surgery, and maintaining health in critically ill patients. Moreover, advancements in medical technology and formulations have spurred the creation of specialized solutions designed to address the nutritional requirements of particular patient groups, such as premature infants, cancer patients, and individuals with gastrointestinal disorders. Additionally, the expanding applications of this nutrition in home healthcare settings and ambulatory care further drive market growth. Furthermore, the growing adoption of total parenteral nutrition (TPN) and peripheral parenteral nutrition (PPN) in hospitals and healthcare facilities and increasing healthcare expenditure and reimbursement policies contribute to the market's expansion. However, regulatory constraints and limited reimbursement options may hinder the market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Parenteral Nutrition. The growth and trends of Parenteral Nutrition industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Parenteral Nutrition market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Nutrient

Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins & Minerals

By Stage

Adult
Pediatrics

By Indication

Alzheimer's
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others

By Sales Channel

Online Sales
Retail Sales
Institutional Sales

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Parenteral Nutrition market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Parenteral Nutrition market include Baxter, Grifols, S.A., Allergan, Otsuka Pharmaceutical Factory Inc., Actavis Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Vifor Pharma, Sichuan Kelun Pharmaceutical Co. Ltd., Pfizer Inc. (Hospira Inc.). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PARENTERAL NUTRITION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Nutrient
- 3.7.2 Market Attractiveness Analysis By Stage
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By Sales Channel
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY NUTRIENT

5.1. Overview By Nutrient
5.2. Historical and Forecast Data
5.3. Analysis By Nutrient
5.4. Carbohydrates Historic and Forecast Sales By Regions
5.5. Parenteral Lipid Emulsion Historic and Forecast Sales By Regions
5.6. Single Dose Amino Acid Solution Historic and Forecast Sales By Regions
5.7. Trace Elements Historic and Forecast Sales By Regions
5.8. Vitamins & Minerals Historic and Forecast Sales By Regions

6. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY STAGE

6.1. Overview By Stage
6.2. Historical and Forecast Data
6.3. Analysis By Stage
6.4. Adult Historic and Forecast Sales By Regions
6.5. Pediatrics Historic and Forecast Sales By Regions

7. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY INDICATION

7.1. Overview By Indication
7.2. Historical and Forecast Data
7.3. Analysis By Indication
7.4. Alzheimer's Historic and Forecast Sales By Regions
7.5. Nutrition Deficiency Historic and Forecast Sales By Regions
7.6. Cancer Care Historic and Forecast Sales By Regions
7.7. Diabetes Historic and Forecast Sales By Regions
7.8. Chronic Kidney Diseases Historic and Forecast Sales By Regions
7.9. Orphan Diseases Historic and Forecast Sales By Regions
7.10. Dysphagia Historic and Forecast Sales By Regions
7.11. Pain Management Historic and Forecast Sales By Regions
7.12. Malabsorption/GI Disorder/Diarrhea Historic and Forecast Sales By Regions
7.13. Others Historic and Forecast Sales By Regions

8. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY SALES CHANNEL

8.1. Overview By Sales Channel
8.2. Historical and Forecast Data
8.3. Analysis By Sales Channel
8.4. Online Sales Historic and Forecast Sales By Regions
8.5. Retail Sales Historic and Forecast Sales By Regions
8.6. Institutional Sales Historic and Forecast Sales By Regions

9. GLOBAL PARENTERAL NUTRITION MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PARENTERAL NUTRITION COMPANIES

10.1. Parenteral Nutrition Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF PARENTERAL NUTRITION INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Baxter
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Grifols
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. S.A.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Allergan
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Otsuka Pharmaceutical Factory Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Actavis Inc.
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. B. Braun Melsungen AG
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Fresenius Kabi AG
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Vifor Pharma
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Sichuan Kelun Pharmaceutical Co. Ltd.
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Pfizer Inc. (Hospira Inc.)
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments